Literature DB >> 21293017

The hidden mismatch: an explanation for infarct growth without perfusion-weighted imaging/diffusion-weighted imaging mismatch in patients with acute ischemic stroke.

Henry K Ma1, Jorge A Zavala, Leonid Churilov, John Ly, Perter M Wright, Thanh G Phan, Shuji Arakawa, Stephen M Davis, Geoffrey A Donnan.   

Abstract

BACKGROUND AND
PURPOSE: In ischemic stroke, MR perfusion-weighted imaging (PWI) and diffusion-weighted imaging (DWI) mismatch represents tissue at risk for infarction. Infarct growth should only take place in the presence of mismatch, although there have been reports of this occurring. We hypothesized that this observation may be attributable to the presence of undetected "hidden mismatch," which may become obvious when coregistration techniques are used.
METHODS: MR PWI/DWI was performed within 48 hours of stroke onset and a final T2-weighted image at ≈3 months. Volumetric-subtraction mismatch volume was defined as PWI minus DWI volume and infarct growth was defined as T2 minus DWI volume. Coregistration mismatch volume was PWI not overlapped by DWI. Mismatch salvage was the proportion of coregistered mismatch tissue that had not progressed to infarction.
RESULTS: Thirty-four patients were studied with MR at a median of 4.9 hours (interquartile range, 2.9-21.1 hours). With the volumetric-subtraction technique, 5 patients (14.7%; 95% CI, 0.05%-0.31%) had infarct growth exceeding mismatch volume, 11 patients (32.0%) had no mismatch and, among these, 3 (27.3%) had infarct growth (median volume, 2.2 mL; interquartile range, 1.0-6.5 mL). All patients had mismatch volume identified by coregistration method that was greater than infarct growth volume. The proportion of this volume salvaged was 77.7% (interquartile range, 63.0%-98.9%).
CONCLUSIONS: The illogical finding of infarct growth volume being greater than the presence of mismatch volume can be explained by the presence of "hidden mismatch," which may be detected by coregistration methods.

Entities:  

Mesh:

Year:  2011        PMID: 21293017     DOI: 10.1161/STROKEAHA.110.593236

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  6 in total

1.  Magnetic resonance diffusion-perfusion mismatch in acute ischemic stroke: An update.

Authors:  Feng Chen; Yi-Cheng Ni
Journal:  World J Radiol       Date:  2012-03-28

2.  Susceptibility Vessel Sign on T2*-Weighted Gradient Echo Imaging in Lacunar Infarction.

Authors:  Mansour Al-Zghloul; Holger Wenz; Máté Maros; Johannes Böhme; Christoph Groden; Alex Förster
Journal:  In Vivo       Date:  2018 Jul-Aug       Impact factor: 2.155

3.  Medical image analysis methods in MR/CT-imaged acute-subacute ischemic stroke lesion: Segmentation, prediction and insights into dynamic evolution simulation models. A critical appraisal.

Authors:  Islem Rekik; Stéphanie Allassonnière; Trevor K Carpenter; Joanna M Wardlaw
Journal:  Neuroimage Clin       Date:  2012-10-17       Impact factor: 4.881

4.  Magnetic resonance perfusion imaging evaluation in perfusion abnormalities of the cerebellum after supratentorial unilateral hyperacute cerebral infarction.

Authors:  Pan Liang; Yunjun Yang; Weijian Chen; Yuxia Duan; Hongqing Wang; Xiaotong Wang
Journal:  Neural Regen Res       Date:  2012-04-25       Impact factor: 5.135

5.  An open-label, one-arm, dose-escalation study to evaluate safety and tolerability of extremely low frequency magnetic fields in acute ischemic stroke.

Authors:  Fioravante Capone; Micaela Liberti; Francesca Apollonio; Francesca Camera; Stefania Setti; Ruggero Cadossi; Carlo Cosimo Quattrocchi; Vincenzo Di Lazzaro
Journal:  Sci Rep       Date:  2017-09-22       Impact factor: 4.379

6.  Novel Estimation of Penumbra Zone Based on Infarct Growth Using Machine Learning Techniques in Acute Ischemic Stroke.

Authors:  Yoon-Chul Kim; Hyung Jun Kim; Jong-Won Chung; In Gyeong Kim; Min Jung Seong; Keon Ha Kim; Pyoung Jeon; Hyo Suk Nam; Woo-Keun Seo; Gyeong-Moon Kim; Oh Young Bang
Journal:  J Clin Med       Date:  2020-06-24       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.